Scenarios of MTC in sufferers addressed with liraglutide, An additional GLP-1 receptor agonist, have been reported in the postmarketing time period; the data in these stories are insufficient to determine or exclude a causal marriage concerning MTC and GLP-1 receptor agonist use in individuals. I